Eric Aguiar

Filings by Eric Aguiar span 2 companies, the busiest being Invitae Corp and BridgeBio Pharma, Inc. In total, 5 filings cover trades dated from 30 April 2021 to 22 June 2026.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

On 24 June 2026 came the latest disclosure, a share grant in BridgeBio Pharma, Inc. Typically, a trade is published a median of 4 days after it takes place. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.